Vivimed Labs share price added nearly 5 percent intraday on October 13 after it received approval for its products.
The company received approvals for 2 ophthalmic products from its state of the art sterile Ophthalmic facility and 2 oral liquid suspension products from its PICS & Health Canada approved site.
Both the facilities are situated at Hyderabad and expecting 5 more approvals in Ophthalmics and Oral solids in 04 CY 2020.
The share touched its 52-week high Rs 23.62 and 52-week low Rs 6.50 on 25 August, 2020 and 23 March, 2020, respectively.
Currently, it is trading 26.33 percent below its 52-week high and 167.69 percent above its 52-week low.
The share gained 41 percent in the last 9 months.
At 09:35 hrs Vivimed Labs was quoting at Rs 17.40, up Rs 0.60, or 3.57 percent on the BSE.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.